Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.4%

5 terminated out of 44 trials

Success Rate

82.8%

-3.7% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

21%

5 of 24 completed with results

Key Signals

5 with results83% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (12)
P 1 (5)
P 2 (11)
P 3 (1)
P 4 (1)

Trial Status

Completed24
Terminated5
Recruiting5
Unknown4
Active Not Recruiting4
Withdrawn1

Trial Success Rate

82.8%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT07038369Phase 1Active Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07382505Not Yet RecruitingPrimary

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

NCT04579380Phase 2Active Not RecruitingPrimary

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT07046949Not ApplicableCompleted

Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies

NCT06953076Recruiting

Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study

NCT03624712RecruitingPrimary

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

NCT06774482RecruitingPrimary

Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms

NCT04061967Not ApplicableRecruiting

Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.

NCT06741046Active Not RecruitingPrimary

RT for Cervical Adenocarcinoma/adenosquamous Carcinoma

NCT00250783Completed

Pre-Clinical Models in Gynecological Tumors A Tissue Repository

NCT02820506Not ApplicableActive Not Recruiting

Sentinel Node Mapping in Women With Endometrial and Cervical Cancer

NCT04679675Not ApplicableCompleted

Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial

NCT00250770WithdrawnPrimary

Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis

NCT00188695Phase 1CompletedPrimary

Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide

NCT02825355Completed

Sentinel Node Mapping in Women With Cervical and Endometrial Cancer

NCT05242861Recruiting

Retrospective Study of Brachytherapy

NCT05004623Not ApplicableCompleted

Early Feasibility Study of the "Easy Light" Fluorecence Imaging System

NCT04063072Not ApplicableUnknownPrimary

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.

NCT03951415Phase 2Unknown

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

NCT01654458Not ApplicableCompleted

A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer

Scroll to load more

Research Network

Activity Timeline